Polymyalgia Rheumatica



  • An inflammatory clinical syndrome characterized by pain and morning stiffness of the shoulder, hip girdles, and neck; primarily impacts patients aged >50 years; associated with morning stiffness and elevated markers of inflammation
  • Can be associated with giant cell arteritis (GCA)
  • System(s) affected: musculoskeletal; hematologic/lymphatic/immunologic
  • Synonym(s): senile rheumatic disease; polymyalgia rheumatica (PMR) syndrome; pseudo-polyarthrite rhizomélique

Geriatric Considerations
Incidence increases with age (age >50 years).

Pediatric Considerations
Rare in patients <50 years of age (1)



  • Incidence increases after age 50 years. Incidence of PMR and GCA in the United States is 50 and 18 per 100,000 people, respectively.
  • Predominant sex: female > male (2 to 3:1)
  • Most common in Caucasians, especially those of Northern European ancestry and in Scandinavian countries
  • Peak incidence occurs between ages 70 and 80 years.

Prevalence in those >50 years old: 700/100,000

Etiology and Pathophysiology

  • Unknown; symptoms relate to enhanced immune system and periarticular inflammatory activity.
  • Pathogenesis
    • Polygenic; involves multiple environmental and genetic factors
    • Significant association between histologic evidence of GCA and parvovirus B19 DNA in temporal artery specimen

Associated with human leukocyte antigen determinants (HLA-DRB1*04 and DRB1*01 alleles)

Risk Factors

  • Aged >50 years
  • Presence of GCA

Commonly Associated Conditions

Concurrent GCA (temporal arteritis) in ~15–30% of patients; more commonly in females than males

There's more to see -- the rest of this topic is available only to subscribers.